Healthy Skepticism Library
Items published during the years 2000 to 2009
There are 14385 items in the Healthy Skepticism Library that were published during the years 2000 to 2009.
Page 96 of 144 pages ‹ First < 94 95 96 97 98 > Last ›
HSL3585
Larger companies still withholding trials info, says study
PM Live.com 2006 Jan 3
http://www.pmlive.com/pharm_market/news.cfm?showArticle=1&ArticleID=4296
HSL4763
By the numbers. Top 20 pharmaceutical companies, ranked by U.S. sales, October 2004 to September 2005.
Mod Healthc. 2006 Jan 2; 36:(1):30
HSL3488
Berenson A.
Antidepressants Seem to Cut Suicide Risk in Teenagers and Adults, Study Says
New York Times 2006 Jan 1
http://query.nytimes.com/search/query?ppds=bylL&v1=ALEX%20BERENSON&fdq=19960101&td=sysdate&sort=newest&ac=ALEX%20BERENSON&inline=nyt-per
HSL3489
Savodnik I.
Psychiatry's sick compulsion: turning weaknesses into diseases
Los Angeles Times 2006 Jan 1
http://www.latimes.com/news/opinion/sunday/editorials/la-op-psych1jan01,0,1868753.story?coll=la-home-sunday-opinion
HSL4547
Fuchs J, Hippius M, Schaefer M.
Analysis of German package inserts.
Int J Clin Pharmacol Ther 2006 Jan; 44:(1):8-13
HSL4858
Wallace LS, Rogers ES, Turner LW, Keenum AJ, Weiss BD.
Suitability of written supplemental materials available on the Internet for nonprescription medications.
Am J Health Syst Pharm 2006 Jan 1; 63:(1):71-8
http://www.ajhp.org/cgi/content/full/63/1/71
HSL4866
Young A.
'Can you prescribe something?'
Health Aff (Millwood). 2006 Jan-Feb;25(1):226-30. 2006 Jan-Feb 01; 25:(1):226-30
http://content.healthaffairs.org/cgi/content/full/25/1/226
HSL4934
Wolfson W.
Holding back the tide of antibiotic resistance.
Chem Biol 2006 Jan 01; 13:(1):1-3
http://linkinghub.elsevier.com/retrieve/pii/S1074-5521(06)00005-6
HSL4935
Roche AM, James MF, Grocott MP, Mythen MG.
Just scratching the surface: varied coagulation effects of polymer containers on TEG variables.
Eur J Anaesthesiol 2006 Jan 01; 23:(1):45-9
http://www.ncbi.nlm.nih.gov/entrez/utils/lofref.fcgi?PrId=3288&uid=16390565&db=PubMed&url=http://journals.cambridge.org/abstract_S0265021505001754
HSL5123
O'Connor EJ, Fiol CM.
Creating readiness and involvement.
Physician Exec 2006 Jan-Feb 01; 32:(1):72-4
HSL5124
Lyles A.
Creating alternative incentives for pharmaceutical innovation.
Clin Ther 2006 Jan 01; 28:(1):126-8
http://www.sciencedirect.com/science?_ob=ArticleURL&_udi=B6VRS-4J9820V-F&_coverDate=01%2F31%2F2006&_alid=413875430&_rdoc=1&_fmt=&_orig=search&_qd=1&_cdi=6242&_sort=d&view=c&_acct=C000050221&_version=1&_urlVersion=0&_userid=10&md5=0974efb1c817dae9d0e3f0198037cbff
HSL5142
Friedman LS, Richter ED.
Excessive and disproportionate advertising in peer-reviewed journals.
Int J Occup Environ Health 2006 Jan-Mar 01; 12:(1):59-64
HSL5144
Chan CH.
The pharmaceutical role.
Acad Psychiatry 2006 Jan-Feb 01; 30:(1):45-7
http://ap.psychiatryonline.org/cgi/content/full/30/1/45
HSL5145
Lazarus A.
The role of the pharmaceutical industry in medical education in psychiatry.
Acad Psychiatry 2006 Jan-Feb 01; 30:(1):40-4
http://ap.psychiatryonline.org/cgi/content/full/30/1/40
HSL5146
Jibson MD.
Medical education and the pharmaceutical industry: managing an uneasy alliance.
Acad Psychiatry 2006 Jan-Feb 01; 30:(1):36-9
http://ap.psychiatryonline.org/cgi/content/full/30/1/36
HSL5157
Skiba M.
Strategies for identifying and minimizing medication errors in health care settings.
Health Care Manag (Frederick) 2006 Jan-Mar 01; 25:(1):70-7
http://meta.wkhealth.com/pt/pt-core/template-journal/lwwgateway/media/landingpage.htm?an=00126450-200601000-00010http://
HSL5160
Kondrak G, Dorr B.
Automatic identification of confusable drug names.
Artif Intell Med 2006 Jan 01; 36:(1):29-42
http://linkinghub.elsevier.com/retrieve/pii/S0933-3657(05)00100-4
HSL5180
Global Corruption Report 2006.
: Transparency International 2006
http://www.transparency.org/publications/gcr/download_gcr
HSL5652
Chur-Hansen A, Zion D.
'Let's fix the chemical imbalance first, and then we can work on the problems second': an exploration of ethical implications of prescribing an SSRI for 'depression'.
Monash Bioeth Rev 2006 Jan 01; 25:(1):15-30
HSL5675
Sethi M, Mishra D.
Display of feeding bottles in advertising renditions.
Indian J Pediatr 2006 Jan 01; 73:(1):104-5
http://www.ijppediatricsindia.org/article.asp?issn=0019-5456;year=2006;volume=73;issue=1;spage=104;epage=105;aulast=Sethi
HSL5780
Yoon EY, Davis MM, El-Essawi H, Cabana MD.
FDA labeling status of pediatric medications.
Clin Pediatr (Phila) 2006 Jan-Feb 01; 45:(1):75-7
HSL5830
De Santo NG.
[Promoting clinical research].
G Ital Nefrol 2006 Jan-Feb 01; 23:
HSL5834
Wen LS, McCoy C.
Response to 'Interactions between pharmaceutical representatives and doctors in training: a thematic review'.
J Gen Intern Med 2006 Jan 01; 21:(1):103
http://www.blackwell-synergy.com/doi/abs/10.1111/j.1525-1497.2005.00271_4.x
HSL5835
Goodman RL, Carrasquillo O.
The corporate co-author, the ghostwriter, and the medical society: an object lesson (June, 2005 issue).
J Gen Intern Med 2006 Jan 01; 21:(1):102
http://www.blackwell-synergy.com/doi/abs/10.1111/j.1525-1497.2005.00271_3.x
HSL5943
Kossoff EH, Mankad DN.
Medication-overuse headache in children: is initial preventive therapy necessary?
J Child Neurol 2006 Jan 01; 21:(1):45-8
http://www.bcdecker.com/pubMedLinkOut.aspx?pub=JCNO&vol=21&iss=1&page=45
HSL6189
Vogenberg FR, Dhir S.
Have consultant pharmacists provided value to long-term care payers?
Consult Pharm 2006 Jan 01; 21:(1):72-5
HSL6311
O'Malley P.
Pharmaceutical advertising and clinical nurse specialist practice.
Clin Nurse Spec 2006 Jan-Feb 01; 20:(1):13-5
http://meta.wkhealth.com/pt/pt-core/template-journal/lwwgateway/media/landingpage.htm?an=00002800-200601000-00005
HSL4711
Flynn G.
The NIH ethics crackdown: a message to the research community.
Ann Emerg Med 2006 Jan; 47:(1):57-60
HSL4741
Aaronson DW.
The 'black box' and allergy drugs
J Allergy Clin Immunol 2006 Jan; 117:(1):40-4
http://www.ncbi.nlm.nih.gov/entrez/utils/lofref.fcgi?PrId=3048&uid=16387582&db=PubMed&url=http://linkinghub.elsevier.com/retrieve/pii/S0091-6749(05)02125-1
HSL4743
Murphy S, Roberts R.
'Black box' 101: How the Food and Drug Administration evaluates, communicates, and manages drug benefit/risk.
J Allergy Clin Immunol 2006 Jan; 117:(1):34-9
http://linkinghub.elsevier.com/retrieve/pii/S0091-6749(05)02325-0
HSL4744
Pearlman DS.
Primum non nocere and 'black box' warnings.
J Allergy Clin Immunol 2006 Jan; 117:(1):30-1
http://linkinghub.elsevier.com/retrieve/pii/S0091-6749(05)02116-0
HSL4745
Szefler SJ, Whelan GJ, Leung DY.
'Black box' warning: wake-up call or overreaction?
J Allergy Clin Immunol 2006 Jan; 117:(1):26-9
http://linkinghub.elsevier.com/retrieve/pii/S0091-6749(05)02509-1
HSL4805
Brekke KR, Kuhn M.
Direct to consumer advertising in pharmaceutical markets.
J Health Econ 2006 Jan; 25:(1):102-30
http://www.sciencedirect.com/science?_ob=ArticleURL&_udi=B6V8K-4HHH4T3-1&_coverDate=01%2F31%2F2006&_alid=403641655&_rdoc=1&_fmt=&_orig=search&_qd=1&_cdi=5873&_sort=d&view=c&_acct=C000050221&_version=1&_urlVersion=0&_userid=10&md5=d15efcddeb52424f0d0d469a23fe6bca
HSL4810
Prescription for trouble: common drugs, hidden dangers Tens of people are at risk.
Consum Rep 2006 Jan; 71:(1):34-9
HSL4811
Drug-name game.
Consum Rep 2006 Jan; 71:(1):9
HSL4812
Frantz S.
Pharma's year of trouble and strife.
Nat Rev Drug Discov 2006 Jan; 5:(1):7-9
HSL4813
Jayaraman KS.
Firms discovering reality of clinical research in India.
Nat Rev Drug Discov 2006 Jan; 5:(1):6
HSL4820
Meadows M.
Promoting safe and effective drugs for 100 years.
FDA Consum 2006 Jan-Feb; 40:(1):14-20
http://www.fda.gov/fdac/features/2006/106_cder.html
HSL4821
Warning on unapproved alternative hormone therapies.
FDA Consum 2006 Jan-Feb; 40:(1):2
http://www.ncbi.nlm.nih.gov/entrez/utils/lofref.fcgi?PrId=4686&uid=16528817&db=PubMed&url=http://www.fda.gov/fdac/departs/2006/106_upd.html#hormone
HSL4833
Privitera M.
Large clinical trials in epilepsy: funding by the NIH versus pharmaceutical industry.
Epilepsy Res 2006 Jan; 68:(1):52-6
http://www.ncbi.nlm.nih.gov/entrez/utils/lofref.fcgi?PrId=3048&uid=16377139&db=PubMed&url=http://linkinghub.elsevier.com/retrieve/pii/S0920-1211(05)00250-0
HSL4848
Windmeijer F, de Laat E, Douven R, Mot E.
Pharmaceutical promotion and GP prescription behaviour.
Health Econ 2006 Jan; 15:(1):5-18
http://www3.interscience.wiley.com/cgi-bin/abstract/110504860/ABSTRACT
HSL4863
Pfizer and Humana join forces on new Medicare Health Support Program.
Dis Manag Advis 2006 Jan; 12:(1):8-9,
HSL4886
Marnell T.
A big issue?
Br J Gen Pract 2006 Jan; 56:(522):57
http://www.ingentaconnect.com/content/rcgp/bjgp/2006/00000056/00000522/art00011?token=004c17f309b4e7268293c62207d673f582f6b6d383a4b3b257b507b6d7a416a387c6b4654276
HSL4887
Finucane TE.
Advertising the new hypnotics.
J Am Geriatr Soc 2006 Jan; 54:(1):170
http://www.blackwell-synergy.com/doi/abs/10.1111/j.1532-5415.2005.00575_1.x
HSL5073
Bhatt A, Sewlikar S.
Registering clinical trials in India.
Natl Med J India 2006 Jan-Feb; 19:(1):1-3
HSL5074
Almirall N.
The ethics of engagement with the pharmaceutical industry.
Mich Med 2006 Jan-Feb; 105:(1):10-2
HSL5079
Breen KJ, Rogers W.
Physicians and the pharmaceutical industry.
Intern Med J 2006 Jan; 36:(1):66-7
http://www.blackwell-synergy.com/doi/abs/10.1111/j.1445-5994.2005.00993.x
HSL7530
Vallance P, Smart TG.
The future of pharmacology.
Br J Pharmacol 2006 Jan; 147:
http://www.nature.com/bjp/journal/v147/n1s/abs/0706454a.html
HSL7700
Thunell L, Milsom I, Schmidt J, Mattsson LA.
Scientific evidence changes prescribing practice--a comparison of the management of the climacteric and use of hormone replacement therapy among Swedish gynaecologists in 1996 and 2003.
BJOG 2006 Jan; 113:(1):15-20
http://www.blackwell-synergy.com/doi/abs/10.1111/j.1471-0528.2005.00805.x
HSL7702
Campbell NR, Tu K, Brant R, Duong-Hua M, McAlister FA; Canadian Hypertension Education Program Outcomes Research Task Force.
The impact of the Canadian Hypertension Education Program on antihypertensive prescribing trends.
Hypertension 2006 Jan; 47:(1):22-8
http://hyper.ahajournals.org/cgi/content/full/47/1/22
HSL7703
Panthee S.
Evaluation of prescribing errors in primary care.
Int J Clin Pharmacol Ther 2006 Jan; 44:(1):50
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=pubmed&cmd=Retrieve&dopt=AbstractPlus&list_uids=16425971&query_hl=32&itool=pubmed_docsum
HSL7717
Kang BM, Kim MR, Park HM, Yoon BK, Lee BS, Chung HW, Cho SH, Choi H, Kim JG.
Attitudes of Korean clinicians to postmenopausal hormone therapy after the Women's Health Initiative study.
Menopause 2006 Jan-Feb; 13:(1):125-9
http://meta.wkhealth.com/pt/pt-core/template-journal/lwwgateway/media/landingpage.htm?doi=10.1097/01.gme.0000191211.51232.9d
HSL10905
Rockhold FW.
Requiring 'independent' statistical analyses for industry sponsored trials?
Pharm Stat 2006 Jan-Mar; 5:(1):5-6
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=17080923&dopt=Abstract
HSL11951
Moghimi Y.
The 'PharmFree' campaign: educating medical students about industry influence.
PLoS Med 2006 Jan; 3:(1):e30
http://medicine.plosjournals.org/perlserv/?request=get-document&doi=10.1371/journal.pmed.0030030
HSL5306
Davis D.
Continuing education, guideline implementation, and the emerging transdisciplinary field of knowledge translation.
J Contin Educ Health Prof 2006 Win 01; 26:(1):5-12
http://www3.interscience.wiley.com/cgi-bin/abstract/112549279/ABSTRACT?CRETRY=1&SRETRY=0
HSL19039
Woloshin S, Schwartz LM
What's the rush? The dissemination and adoption of preliminary research results.
J Natl Cancer Inst 2006 15; 98:(6):372-3
http://jnci.oxfordjournals.org/content/98/6/372.long
HSL4607
Doherty S.
Evidence-based implementation of evidence-based guidelines.
Int J Health Care Qual Assur Inc Leadersh Health Serv 2006; 19:(1):32-41
HSL4633
Seeman N, Brown AD.
Remembering Peter Drucker: inspiring the quality revolution in healthcare.
Healthc Q 2006; 9:(1):50-2,
HSL4708
Caplovitz A
Turning Medicine Into Snake Oil: How Pharmaceutical Marketers put Patients at Risk
Trenton NJ: NJPIRG Law and Policy Center 2006
http://njpirg.org/reports/TurningMedintoSnakeOil.pdf
HSL4844
Loken B.
Consumer psychology: categorization, inferences, affect, and persuasion.
Annu Rev Psychol 2006; 57:453-85
http://www.ncbi.nlm.nih.gov/entrez/utils/lofref.fcgi?PrId=4487&uid=16318603&db=PubMed&url=http://dx.doi.org/10.1146/annurev.psych.57.102904.190136
HSL4845
Crano WD, Prislin R.
Attitudes and persuasion.
Annu Rev Psychol 2006; 57:345-74
http://arjournals.annualreviews.org/doi/abs/10.1146/annurev.psych.57.102904.190034
HSL4849
Wogart JP, Calcagnotto G.
Brazil's fight against AIDS and its implications for global health governance.
Healthc Q 2006; 9:(1):76-89
HSL4881
Horejsi J.
[Do you know what you are reading?]
Cas Lek Cesk 2006; 145:(2):163-4
HSL4899
Hasman A, Holm S.
Direct-to-consumer advertising: should there be a free market in healthcare information?
Camb Q Healthc Ethics 2006 Win; 15:(1):42-9
HSL4900
Dutta-Bergman MJ.
A formative approach to strategic message targeting through soap operas: using selective processing theories.
Health Commun 2006; 19:(1):11-8
http://www.ncbi.nlm.nih.gov/entrez/utils/lofref.fcgi?PrId=4487&uid=16519588&db=PubMed&url=http://dx.doi.org/10.1207/s15327027hc1901_2
HSL4922
Montori VM, Leung TW, Devereaux PJ, Schunemann HJ, Akl EA, Gafni A, Guyatt GH.
Can contraindications compromise evidence-based, patient-centered clinical practice?
Can J Clin Pharmacol 2006 Win; 13:(1):e92-101
HSL4995
Boggs W.
Meeting presentations can influence treatment patterns
J Natl Cancer Inst 2006; 98:372-373,382-388.
http://www.medscape.com/viewarticle/527662
HSL4998
Busfield J.
Pills, Power, People: Sociological Understandings of the Pharmaceutical Industry
2006; 40:(2):297-314
http://soc.sagepub.com/cgi/content/abstract/40/2/297?etoc
HSL5054
Polimeni G, Salvo F, Cutroneo P, Morreale I, Patrizio Caputi A.
Adverse reactions induced by NSAIDs and antibacterials : analysis of spontaneous reports from the sicilian regional database.
Drug Saf 2006; 29:(5):449-59
HSL5078
Lee R.
FDA and drug safety: new Tufts study challenges critics of the Prescription Drug User Fee Act.
J Law Med Ethics 2006 Spr; 34:(1):131-4
HSL5196
Lough M.
What the educators are saying
BMJ 2006; 332:(7555):1450
http://bmj.bmjjournals.com/cgi/content/short/332/7555/1450?etoc
HSL5387
Del Mar C
Clinical Thinking: Evidence, Communication and Decision-Making
London: BMJ Publishing 2006
HSL5416
Mitchell TB, Dyer KR, Peay ER.
Patient and physician characteristics in relation to clinical decision making in methadone maintenance treatment.
Subst Use Misuse 2006; 41:(3):393-404
http://taylorandfrancis.metapress.com/(vd040writt1bijmrlvrij5qj)/app/home/contribution.asp?referrer=parent&backto=issue,9,11;journal,5,59;linkingpublicationresults,1:107866,1
HSL5437
Vernon JA, Johnson SJ, Hughen WK, Trujillo A.
Economic and developmental considerations for pharmacogenomic technology.
Pharmacoeconomics 2006; 24:(4):335-43
HSL5438
Hughes D.
Rationing of drugs for rare diseases.
Pharmacoeconomics 2006; 24:(4):315-6
HSL5543
Breggin PR
Court filing makes public my previously suppressed analysis of Paxil's effects.
Ethical Human Psychology and Psychiatry 2006 Spr; 8:(1):77-84
http://www.springerpub.com/
HSL5553
Wakefield M, Durrant R.
Effects of exposure of youths at risk for smoking to television advertising for nicotine replacement therapy and Zyban: an experimental study.
Health Commun 2006; 19:(3):253-8
http://www.leaonline.com/doi/abs/10.1207/s15327027hc1903_7
HSL5554
Campo S, Cameron KA.
Differential effects of exposure to social norms campaigns: a cause for concern.
Health Commun 2006; 19:(3):209-19
http://www.leaonline.com/doi/abs/10.1207/s15327027hc1903_3
HSL5576
Greenhalgh T, Russell J.
Promoting the skills of knowledge translation in an online master of science course in primary health care.
J Contin Educ Health Prof 2006 Spr; 26:(2):100-8
http://www3.interscience.wiley.com/cgi-bin/abstract/112660759/ABSTRACT?CRETRY=1&SRETRY=0
HSL5651
Rohra DK, Gilani AH, Memon IK, Perven G, Khan MT, Zafar H, Kumar R.
Critical evaluation of the claims made by pharmaceutical companies in drug promotional material in Pakistan.
J Pharm Pharm Sci 2006; 9:(1):50-9
http://www.ualberta.ca/~csps/JPPS9(1)/Rohra.D/promotion.htm
HSL5752
Centre for science in the public interest
Ensuring Independence and Objectivity at The National Academies
Washington, DC: Centre for science in the public interest 2006
http://cspinet.org/new/pdf/nasreport.pdf
HSL5777
Skala N, Hellander I.
A review of data on the U.S. health sector: summer 2005.
Int J Health Serv 2006; 36:(1):157-76
HSL5822
Evans BJ, Flockhart DA.
The unfinished business of U.S. drug safety regulation.
Food Drug Law J 2006; 61:(1):45-63
HSL5927
Sharp RR, Yarborough M.
Informed trust and the financing of biomedical research.
J Law Med Ethics 2006 Sum; 34:(2):460-4
http://www.blackwell-synergy.com/doi/abs/10.1111/j.1748-720X.2006.00052.x
HSL5930
Vuorenkoski L.
[The case of rofecoxib(Vioxx)-what do we learn from this case].
Duodecim 2006; 122:(4):385-6
HSL5951
Bayer erectile dysfunction drug found to breach
Choice : Australian Consumers' Association Date uncertain 2006
HSL5970
Lauer CD, Turp JC.
[Without risks and side effects? Product advertisements in dental journals]
Schweiz Monatsschr Zahnmed 2006; 116:(7):718-24
HSL5978
Masereel B.
[Critical review of new chemical and biological molecules launched in Belgium during the period 2001-2005].
J Pharm Belg 2006; 61:(2):45-57
HSL5989
Davenport J.
Is your advertising a liability risk?
J N J Dent Assoc 2006 Spr; 77:(2):31
HSL5992
Dresser R.
Private-sector research ethics: marketing or good conflicts management The 2005 John J. Conley Lecture on Medical Ethics
Theor Med Bioeth. 2006;27(2):115-39 2006; 27:(2):115-39
http://www.springerlink.com/content/bq855531108k52p6/
HSL5999
Kuczkowski KM.
Drug mislabeling erros in (obsteric) anaesthesia.
Acta Anaesthesiol Belg 2006; 57:(1):57
HSL6000
Datti B, Carter MW.
The effect of direct-to-consumer advertising on prescription drug use by older adults.
Drugs Aging 2006; 23:(1):71-81
HSL6073
Bradford WD, Kleit AN, Nietert PJ, Steyer T, McIlwain T, Ornstein S.
How Direct-To-Consumer Television Advertising For Osteoarthritis Drugs Affects Physicians' Prescribing Behavior.
Health Aff 2006 Sep-Oct; 25:(5):1371-1377
http://content.healthaffairs.org/cgi/content/full/25/5/1371
HSL6080
Liebenberg W.
Another white lie?
J Esthet Restor Dent 2006; 18:(3):155-60
http://www.blackwell-synergy.com/doi/abs/10.1111/j.1708-8240.2006.00002.x
HSL6081
Manley PA.
Communicate first.
Mark Health Serv 2006 Sum; 26:(2):42
HSL6082
Cho H, Salmon CT.
Fear appeals for individuals in different stages of change: intended and unintended effects and implications on public health campaigns.
Health Commun 2006; 20:(1):91-9
http://www.leaonline.com/doi/abs/10.1207/s15327027hc2001_9
HSL6120
Manthei JR, Hathaway CR, Grant MA, Chung DD.
Merck v Integra: Supreme Court permits use of patented compounds to obtain Food and Drug Administration approvals.
Food Drug Law J 2006; 61:(2):273-7
HSL6157
Hullett CR.
Using functional theory to promote HIV testing: the impact of value-expressive messages, uncertainty, and fear.
Health Commun 2006; 20:(1):57-67
http://www.leaonline.com/doi/abs/10.1207/s15327027hc2001_6
HSL6158
Polonec LD, Major AM, Atwood LE.
Evaluating the believability and effectiveness of the social norms message 'most students drink 0 to 4 drinks when they party'.
Health Commun 2006; 20:(1):23-34
http://www.leaonline.com/doi/abs/10.1207/s15327027hc2001_3
HSL6159
Smith SW, Atkin CK, Roznowski J.
Are 'drink responsibly' alcohol campaigns strategically ambiguous?
Health Commun 2006; 20:(1):1-11
http://www.leaonline.com/doi/abs/10.1207/s15327027hc2001_1
Page 96 of 144 pages ‹ First < 94 95 96 97 98 > Last ›
